Protocolo para produção de material propagativo de batata em meio líquido Protocol for potato propagative material production in liquid medium

Os meios semi-sólidos são os mais utilizados em trabalhos de micropropagação, mas há indícios de que o estado físico dos meios de cultura influencia a multiplicação dos cultivos. O objetivo deste trabalho foi estabelecer um protocolo para a multiplicação de material propagativo de batata em meio de cultura líquido. Explantes de batata da cultivar Eliza, com uma gema axilar, foram cultivados em seis diferentes meios de cultura, com (semi-sólido) ou sem (líquido) a adição do solidificante ágar. Após 21 dias de cultivo, o meio de cultura que proporcionou os melhores resultados para crescimento e taxa de multiplicação teve sua composição modificada com o objetivo de melhorar a eficiência de multiplicação de cinco cultivares em meio líquido. Foi também avaliada a necessidade de agitação dos cultivos em meio líquido. Houve ganho na eficiência de multiplicação in vitro da batata, quando se utiliza meio de cultura líquido. Os melhores resultados são obtidos quando o material é cultivado em meio constituído pelos sais de MS na concentração plena, acrescido de ácido pantotênico (5,0 mg L-1), tiamina (1,0 mg L-1), ácido giberélico (0,25 mg L-1) e sacarose (20 g L-1), sob agitação constante.<br>Semi-solid media are more commonly used in studies of micropropagation, but the physical state of the culture media seems to influence the growth and multiplication rate of the cultivation. The objective of this work was to establish a protocol for in vitro multiplication of potato in liquid culture media. Potato explants, cultivar Eliza, with an axillary bud, were cultivated in six different culture media, with (semi-solid) or without (liquid) the addition of agar. After 21 days, the culture medium that provided the best results for growth and multiplication rate had the composition modified with the objective of improving the efficiency of in vitro multiplication of five cultivars in liquid medium. The need of agitation was also evaluated in liquid culture medium. There was high efficiency of the in vitro potato multiplication when it was cultivated in liquid medium. The MS salt medium in the full concentration, added by gibberellic acid (0.25 mg L-1), panthotenic acid (5.0 mg L-1), thiamine (1.0 mg L-1) and sucrose (20 g L-1), and under constant agitation, showed to be suitable for this purpose

Identification of symbol digit modality test score extremes in Huntington's disease

Studying individuals with extreme phenotypes could facilitate the understanding of disease modification by genetic or environmental factors. Our aim was to identify Huntington's disease (HD) patients with extreme symbol digit modality test (SDMT) scores. We first examined in HD the contribution of cognitive measures of the Unified Huntington's Disease Rating Scale (UHDRS) in predicting clinical endpoints. The language-independent SDMT was used to identify patients performing very well or very poorly relative to their CAG and age cohort. We used data from REGISTRY and COHORT observational study participants (5,603 HD participants with CAG repeats above 39 with 13,868 visits) and of 1,006 healthy volunteers (with 2,241 visits), included to identify natural aging and education effects on cognitive measures. Separate Cox proportional hazards models with CAG, age at study entry, education, sex, UHDRS total motor score and cognitive (SDMT, verbal fluency, Stroop tests) scores as covariates were used to predict clinical endpoints. Quantile regression for longitudinal language-independent SDMT data was used for boundary (2.5% and 97.5% quantiles) estimation and extreme score analyses stratified by age, education, and CAG repeat length. Ten percent of HD participants had an extreme SDMT phenotype for at least one visit. In contrast, only about 3% of participants were consistent SDMT extremes at two or more visits. The thresholds for the one-visit and two-visit extremes can be used to classify existing and new individuals. The identification of these phenotype extremes can be useful in the search for disease modifiers.Neurological Motor Disorder

Clinical and genetic characteristics of late-onset Huntington's disease

Background: The frequency of late-onset Huntington's disease (&gt;59 years) is assumed to be low and the clinical course milder. However, previous literature on late-onset disease is scarce and inconclusive. Objective: Our aim is to study clinical characteristics of late-onset compared to common-onset HD patients in a large cohort of HD patients from the Registry database. Methods: Participants with late- and common-onset (30\u201350 years)were compared for first clinical symptoms, disease progression, CAG repeat size and family history. Participants with a missing CAG repeat size, a repeat size of 6435 or a UHDRS motor score of 645 were excluded. Results: Of 6007 eligible participants, 687 had late-onset (11.4%) and 3216 (53.5%) common-onset HD. Late-onset (n = 577) had significantly more gait and balance problems as first symptom compared to common-onset (n = 2408) (P &lt;.001). Overall motor and cognitive performance (P &lt;.001) were worse, however only disease motor progression was slower (coefficient, 120.58; SE 0.16; P &lt;.001) compared to the common-onset group. Repeat size was significantly lower in the late-onset (n = 40.8; SD 1.6) compared to common-onset (n = 44.4; SD 2.8) (P &lt;.001). Fewer late-onset patients (n = 451) had a positive family history compared to common-onset (n = 2940) (P &lt;.001). Conclusions: Late-onset patients present more frequently with gait and balance problems as first symptom, and disease progression is not milder compared to common-onset HD patients apart from motor progression. The family history is likely to be negative, which might make diagnosing HD more difficult in this population. However, the balance and gait problems might be helpful in diagnosing HD in elderly patients

Clinical and genetic characteristics of late-onset Huntington's disease

Background: The frequency of late-onset Huntington's disease (&gt;59 years) is assumed to be low and the clinical course milder. However, previous literature on late-onset disease is scarce and inconclusive. Objective: Our aim is to study clinical characteristics of late-onset compared to common-onset HD patients in a large cohort of HD patients from the Registry database. Methods: Participants with late- and common-onset (30–50 years)were compared for first clinical symptoms, disease progression, CAG repeat size and family history. Participants with a missing CAG repeat size, a repeat size of ≤35 or a UHDRS motor score of ≤5 were excluded. Results: Of 6007 eligible participants, 687 had late-onset (11.4%) and 3216 (53.5%) common-onset HD. Late-onset (n = 577) had significantly more gait and balance problems as first symptom compared to common-onset (n = 2408) (P &lt;.001). Overall motor and cognitive performance (P &lt;.001) were worse, however only disease motor progression was slower (coefficient, −0.58; SE 0.16; P &lt;.001) compared to the common-onset group. Repeat size was significantly lower in the late-onset (n = 40.8; SD 1.6) compared to common-onset (n = 44.4; SD 2.8) (P &lt;.001). Fewer late-onset patients (n = 451) had a positive family history compared to common-onset (n = 2940) (P &lt;.001). Conclusions: Late-onset patients present more frequently with gait and balance problems as first symptom, and disease progression is not milder compared to common-onset HD patients apart from motor progression. The family history is likely to be negative, which might make diagnosing HD more difficult in this population. However, the balance and gait problems might be helpful in diagnosing HD in elderly patients